While reporting financial results for the first quarter on Thursday, Charles River Laboratories International, Inc. (CRL) slashed its earnings and revenue growth guidance for the full-year 2020, due to the global COVID-19 pandemic and its expected impact on the operations, client demand, and financial results.
from RTT - Earnings https://ift.tt/3drXsoi
via IFTTT
No comments:
Post a Comment